These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19403987)

  • 1. Heparin cofactor II is an independent protective factor against peripheral arterial disease in elderly subjects with cardiovascular risk factors.
    Aihara K; Azuma H; Akaike M; Kurobe H; Takamori N; Ikeda Y; Sumitomo Y; Yoshida S; Yagi S; Iwase T; Ishikawa K; Sata M; Kitagawa T; Matsumoto T
    J Atheroscler Thromb; 2009 Apr; 16(2):127-34. PubMed ID: 19403987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin cofactor II is a novel protective factor against carotid atherosclerosis in elderly individuals.
    Aihara K; Azuma H; Takamori N; Kanagawa Y; Akaike M; Fujimura M; Yoshida T; Hashizume S; Kato M; Yamaguchi H; Kato S; Ikeda Y; Arase T; Kondo A; Matsumoto T
    Circulation; 2004 Jun; 109(22):2761-5. PubMed ID: 15148272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased heparin cofactor II activity is associated with impaired endothelial function determined by brachial ultrasonography and predicts cardiovascular events.
    Huang PH; Leu HB; Chen JW; Wu TC; Lu TM; Yu-An Ding P; Lin SJ
    Int J Cardiol; 2007 Jan; 114(2):152-8. PubMed ID: 16650906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin cofactor II attenuates vascular remodeling in humans and mice.
    Aihara K
    Circ J; 2010 Aug; 74(8):1518-23. PubMed ID: 20671370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High plasma heparin cofactor II activity is associated with reduced incidence of in-stent restenosis after percutaneous coronary intervention.
    Takamori N; Azuma H; Kato M; Hashizume S; Aihara K; Akaike M; Tamura K; Matsumoto T
    Circulation; 2004 Feb; 109(4):481-6. PubMed ID: 14744972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin cofactor II as a novel vascular protective factor against atherosclerosis.
    Aihara K; Azuma H; Akaike M; Sata M; Matsumoto T
    J Atheroscler Thromb; 2009 Oct; 16(5):523-31. PubMed ID: 19729870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High plasma heparin cofactor II activity protects from restenosis after femoropopliteal stenting.
    Schillinger M; Exner M; Sabeti S; Mlekusch W; Amighi J; Handler S; Quehenberger P; Kalifeh N; Wagner O; Minar E
    Thromb Haemost; 2004 Nov; 92(5):1108-13. PubMed ID: 15543340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma heparin cofactor II activity is an independent predictor of future cardiovascular events in patients after acute myocardial infarction.
    Huang SS; Huang PH; Chen YH; Sung SH; Chiang KH; Chen JW; Lin SJ
    Coron Artery Dis; 2008 Dec; 19(8):597-602. PubMed ID: 18971786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma heparin cofactor II activity is inversely associated with albuminuria and its annual deterioration in patients with diabetes.
    Hara T; Uemoto R; Sekine A; Mitsui Y; Masuda S; Kurahashi K; Yoshida S; Otoda T; Yuasa T; Kuroda A; Ikeda Y; Endo I; Honda S; Yoshimoto K; Kondo A; Tamaki T; Matsumoto T; Matsuhisa M; Abe M; Aihara KI
    J Diabetes Investig; 2021 Dec; 12(12):2172-2182. PubMed ID: 34043882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma heparin cofactor II activity is inversely associated with left atrial volume and diastolic dysfunction in humans with cardiovascular risk factors.
    Ise T; Aihara K; Sumitomo-Ueda Y; Yoshida S; Ikeda Y; Yagi S; Iwase T; Yamada H; Akaike M; Sata M; Matsumoto T
    Hypertens Res; 2011 Feb; 34(2):225-31. PubMed ID: 21107326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of unrecognized peripheral arterial disease (PAD) using ankle-brachial index in high cardiovascular risk patients free from symptomatic PAD.
    Mourad JJ; Cacoub P; Collet JP; Becker F; Pinel JF; Huet D; Sevestre-Pietri MA; Priollet P;
    J Vasc Surg; 2009 Sep; 50(3):572-80. PubMed ID: 19560312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ankle-brachial index is lower in hypertensive than in normotensive individuals in a cardiovascular risk population.
    Korhonen PE; Syvänen KT; Vesalainen RK; Kantola IM; Kautiainen H; Järvenpää S; Aarnio PT
    J Hypertens; 2009 Oct; 27(10):2036-43. PubMed ID: 19587608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of peripheral arterial obstructive disease related factors among diabetic population aged > or = 50].
    Guan H; Liu ZM; Li GW; Guo XH; Xu ZR; Zou DJ; Xing HL; Liu W; Sheng ZY; Tian HM; Zhu DL; Yu DM; Zhuang WT; Chen LL; Weng JP
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):23-7. PubMed ID: 17403307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular dermatan sulfate and heparin cofactor II.
    Tollefsen DM
    Prog Mol Biol Transl Sci; 2010; 93():351-72. PubMed ID: 20807652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral arterial disease in patients with stages IV and V chronic renal failure.
    Guerrero A; Montes R; Muñoz-Terol J; Gil-Peralta A; Toro J; Naranjo M; González-Pérez P; Martín-Herrera C; Ruiz-Fernández A
    Nephrol Dial Transplant; 2006 Dec; 21(12):3525-31. PubMed ID: 16940320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using ankle-brachial index to detect peripheral arterial disease: prevalence and associated risk factors in a random population sample.
    Carbayo JA; Divisón JA; Escribano J; López-Abril J; López de Coca E; Artigao LM; Martínez E; Sanchis C; Massó J; Carrión L;
    Nutr Metab Cardiovasc Dis; 2007 Jan; 17(1):41-9. PubMed ID: 17174225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of borderline peripheral arterial disease to cardiovascular disease risk.
    Menke A; Muntner P; Wildman RP; Dreisbach AW; Raggi P
    Am J Cardiol; 2006 Nov; 98(9):1226-30. PubMed ID: 17056334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An enzyme-linked immunosorbent assay for heparin cofactor II (HCII). Application to the measurement of HCII in clinical materials.
    Toulon P; Costa JM; Amiral J
    Clin Chim Acta; 1992 Jan; 205(1-2):65-73. PubMed ID: 1521342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower extremity peripheral arterial disease in hospitalized patients with coronary artery disease.
    Dieter RS; Tomasson J; Gudjonsson T; Brown RL; Vitcenda M; Einerson J; McBride PE
    Vasc Med; 2003 Nov; 8(4):233-6. PubMed ID: 15125482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ankle brachial index as a marker of atherosclerosis in Chinese patients with high cardiovascular risk.
    Hasimu B; Li J; Nakayama T; Yu J; Yang J; Li X; Hu D
    Hypertens Res; 2006 Jan; 29(1):23-8. PubMed ID: 16715650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.